Home/Filings/4/0000899866-17-000054
4//SEC Filing

ALEXION PHARMACEUTICALS INC 4

Accession 0000899866-17-000054

CIK 0000899866operating

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 7:44 PM ET

Size

12.3 KB

Accession

0000899866-17-000054

Insider Transaction Report

Form 4
Period: 2017-02-27
Wagner Heidi L
SVP, Global Government Affairs
Transactions
  • Sale

    Common Stock, par value $.0001 per share

    2017-02-27$131.20/sh358$46,97029,646 total
  • Award

    Common Stock, par value $.0001 per share

    2017-02-28+4,40033,410 total
  • Award

    Option to Purchase Common Stock

    2017-02-28+8,7008,700 total
    Exercise: $131.25From: 2018-02-28Exp: 2027-02-28Common Stock, par value $.0001 per share (8,700 underlying)
  • Sale

    Common Stock, par value $.0001 per share

    2017-02-28$131.70/sh480$63,21629,166 total
  • Sale

    Common Stock, par value $.0001 per share

    2017-03-01$132.50/sh156$20,67029,010 total
Footnotes (5)
  • [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
  • [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $131.00 - $131.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $132.00 - $132.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
  • [F4]Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date.
  • [F5]Stock option award under 2004 Incentive Plan. 25% vest on the first anniversary of the grant date, 1/16 every three months thereafter until fully vested over 4 years.

Issuer

ALEXION PHARMACEUTICALS INC

CIK 0000899866

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000899866

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:44 PM ET
Size
12.3 KB